Literature DB >> 15810051

Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.

Joakim Bergström1, Asa Gustavsson, Ulf Hellman, Knut Sletten, Charles L Murphy, Deborah T Weiss, Alan Solomon, Bert-Ove Olofsson, Per Westermark.   

Abstract

The pathological fibrillar deposits found in the heart and other organs of patients with senile systemic amyloidosis (SSA) and Swedish familial amyloidotic polyneuropathy (FAP) contain wild-type (wt) and a mutant form of transthyretin (TTR), respectively. Previously, it was reported that these two forms of amyloid have different molecular features and it was thus postulated that the mechanism responsible for TTR fibrillogenesis in SSA and FAP may differ. To document further the nature of the amyloid in these entities, detailed morphological, histochemical, immunological, and structural analyses of specimens obtained from 14 individuals with SSA and 11 Swedish FAP patients have been performed. Two distinct patterns of amyloid deposition (designated A and B) were evident. In pattern A, found in all SSA and five of 11 FAP cases, the amyloid had a homogeneous but patchy distribution within the sub-endocardium, sub-epicardium, and myocardium; exhibited weak congophilia and green birefringence; and was composed of tightly packed, short, unorientated fibrils. This material contained mainly approximately 79-residue C-terminal fragments of the amyloidogenic precursor protein. In pattern B, seen in the six other FAP patients, the amyloid appeared as thin streaks throughout the cardiac tissue; often surrounded individual muscle cells; was strongly congophilic and birefringent; had long fibrils arranged in parallel bundles, often penetrating into myocytes; and was composed of virtually intact TTR molecules. These findings provide substantive evidence for the morphological and structural heterogeneity of TTR fibrils and suggest that the two types of deposition may reflect fundamental differences in the pathogenesis of the TTR-associated amyloidoses. Copyright 2005 Pathological Society of Great Britain and Ireland

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15810051     DOI: 10.1002/path.1759

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  68 in total

Review 1.  [Amyloidosis of the heart].

Authors:  A V Kristen; C Röcken
Journal:  Pathologe       Date:  2012-05       Impact factor: 1.011

Review 2.  [Amyloid and amyloidoses].

Authors:  C Röcken; M Eriksson
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

3.  Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition.

Authors:  Lorena Saelices; Kevin Chung; Ji H Lee; Whitaker Cohn; Julian P Whitelegge; Merrill D Benson; David S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-28       Impact factor: 11.205

4.  Crystal structures of amyloidogenic segments of human transthyretin.

Authors:  Lorena Saelices; Stuart A Sievers; Michael R Sawaya; David S Eisenberg
Journal:  Protein Sci       Date:  2018-06-13       Impact factor: 6.725

5.  Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis.

Authors:  Akihiro Yanagisawa; Mitsuharu Ueda; Takanao Sueyoshi; Tatsuya Okada; Toru Fujimoto; Yasuhiro Ogi; Keisuke Kitagawa; Masayoshi Tasaki; Yohei Misumi; Toshinori Oshima; Hirofumi Jono; Konen Obayashi; Kei Hirakawa; Hitoshi Uchida; Per Westermark; Yukio Ando; Hiroshi Mizuta
Journal:  Mod Pathol       Date:  2014-09-05       Impact factor: 7.842

6.  A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils.

Authors:  Lorena Saelices; Binh A Nguyen; Kevin Chung; Yifei Wang; Alfredo Ortega; Ji H Lee; Teresa Coelho; Johan Bijzet; Merrill D Benson; David S Eisenberg
Journal:  J Biol Chem       Date:  2019-02-07       Impact factor: 5.157

7.  Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid disease.

Authors:  Elena S Klimtchuk; Tatiana Prokaeva; Nicholas M Frame; Hassan A Abdullahi; Brian Spencer; Surendra Dasari; Haili Cui; John L Berk; Paul J Kurtin; Lawreen H Connors; Olga Gursky
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

8.  Electron tomography reveals the fibril structure and lipid interactions in amyloid deposits.

Authors:  Marius Kollmer; Katrin Meinhardt; Christian Haupt; Falk Liberta; Melanie Wulff; Julia Linder; Lisa Handl; Liesa Heinrich; Cornelia Loos; Matthias Schmidt; Tatiana Syrovets; Thomas Simmet; Per Westermark; Gunilla T Westermark; Uwe Horn; Volker Schmidt; Paul Walther; Marcus Fändrich
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-02       Impact factor: 11.205

9.  Polymorphism of Amyloid Fibrils In Vivo.

Authors:  Karthikeyan Annamalai; Karl-Heinz Gührs; Rolf Koehler; Matthias Schmidt; Henri Michel; Cornelia Loos; Patricia M Gaffney; Christina J Sigurdson; Ute Hegenbart; Stefan Schönland; Marcus Fändrich
Journal:  Angew Chem Int Ed Engl       Date:  2016-03-08       Impact factor: 15.336

10.  Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients.

Authors:  Joseph D Schonhoft; Cecilia Monteiro; Lars Plate; Yvonne S Eisele; John M Kelly; Daniel Boland; Christopher G Parker; Benjamin F Cravatt; Sergio Teruya; Stephen Helmke; Mathew Maurer; John Berk; Yoshiki Sekijima; Marta Novais; Teresa Coelho; Evan T Powers; Jeffery W Kelly
Journal:  Sci Transl Med       Date:  2017-09-13       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.